As of April 16, 2025, Pharvaris (PHVS) has a market cap of $0.76 billion USD. According to our data, Pharvaris is ranked No.5424 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.76 B |
-26.93%
|
Dec 31, 2024 | $1.04 B |
-31.66%
|
Dec 29, 2023 | $1.52 B |
149.33%
|
Dec 30, 2022 | $0.61 B |
-21.82%
|
Dec 31, 2021 | $0.78 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.55 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() KalVista Pharmaceuticals
KALV
|
$0.60 B |
-0.000 M
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Carlisle Companies
CSL
|
$15.55 B |
-0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
Market Cap | = | PHVS Stock Price | * | PHVS Shares Outstanding |
= | $13.94 | * | 54.49 M | |
= | $0.76 B |